aluates Reports

$ 0.0

Automative

Global Celecoxib Market Insights, Forecast to 2030

Published Date: August 2024

Report Code: QYRE-Auto-26G8960

BUY CHAPTERS

Global Celecoxib Market Insights, Forecast to 2030

Code: QYRE-Auto-26G8960

Report

August 2024

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

TEVA

Mylan NV

Apotex

Lupin Ltd

Hengrui Medicine

Celecoxib Market Size

The global Celecoxib market is projected to grow from US$ 1387.2 million in 2024 to US$ 2250.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast period.

Celecoxib Market

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

Data show that more than 400 million people worldwide are currently affected by joint diseases.

The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.

The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.

At present, the burden of chronic diseases will increase by 40% due to the aging of the population.

As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.

Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.

At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.

At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.

It accounted for 63.39% of the global market in 2019.

As of 2019, China relies entirely on Pfizer for celecoxib imports.

Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.

Report Covers:

This report presents an overview of global market for Celecoxib, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Celecoxib, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Celecoxib, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Celecoxib sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Celecoxib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Celecoxib sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Celecoxib Market Report

Report Metric	Details
Report Name	Celecoxib Market
Accounted market size in 2024	US$ 1387.2 in million
Forecasted market size in 2030	US$ 2250.6 million
CAGR	8.4
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	50mg 100mg 200mg 400mg
Segment by Application	Rheumatoid arthritis osteoarthritis Acute pain Musculoskeletal pain Other diseases
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mylan, Apotex, Lupin, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Celecoxib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Celecoxib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Celecoxib sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Celecoxib Market growing?

Ans: The Celecoxib Market witnessing a CAGR of 8.4 during the forecast period 2024-2030.

What is the Celecoxib Market size in 2030?

Ans: The Celecoxib Market size in 2030 will be US$ 2250.6 million.

What is the Celecoxib Market share by region?

Ans: The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.

Who are the main players in the Celecoxib Market report?

Ans: The main players in the Celecoxib Market are Mylan, Apotex, Lupin, Hengrui Medicine

What are the Application segmentation covered in the Celecoxib Market report?

Ans: The Applications covered in the Celecoxib Market report are Rheumatoid arthritis, osteoarthritis, Acute pain, Musculoskeletal pain, Other diseases

What are the Type segmentation covered in the Celecoxib Market report?

Ans: The Types covered in the Celecoxib Market report are 50mg, 100mg, 200mg, 400mg

1 Study Coverage

1.1 Celecoxib Product Introduction

1.2 Market by Type

1.2.1 Global Celecoxib Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 50mg

1.2.3 100mg

1.2.4 200mg

1.2.5 400mg

1.3 Market by Application

1.3.1 Global Celecoxib Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Rheumatoid arthritis

1.3.3 osteoarthritis

1.3.4 Acute pain

1.3.5 Musculoskeletal pain

1.3.6 Other diseases

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Celecoxib Sales Estimates and Forecasts 2019-2030

2.2 Global Celecoxib Revenue by Region

2.2.1 Global Celecoxib Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Celecoxib Revenue by Region (2019-2024)

2.2.3 Global Celecoxib Revenue by Region (2025-2030)

2.2.4 Global Celecoxib Revenue Market Share by Region (2019-2030)

2.3 Global Celecoxib Sales Estimates and Forecasts 2019-2030

2.4 Global Celecoxib Sales by Region

2.4.1 Global Celecoxib Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Celecoxib Sales by Region (2019-2024)

2.4.3 Global Celecoxib Sales by Region (2025-2030)

2.4.4 Global Celecoxib Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Celecoxib Sales by Manufacturers

3.1.1 Global Celecoxib Sales by Manufacturers (2019-2024)

3.1.2 Global Celecoxib Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Celecoxib in 2023

3.2 Global Celecoxib Revenue by Manufacturers

3.2.1 Global Celecoxib Revenue by Manufacturers (2019-2024)

3.2.2 Global Celecoxib Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Celecoxib Revenue in 2023

3.3 Global Key Players of Celecoxib, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Celecoxib Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Celecoxib, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Celecoxib, Product Offered and Application

3.8 Global Key Manufacturers of Celecoxib, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Celecoxib Sales by Type

4.1.1 Global Celecoxib Historical Sales by Type (2019-2024)

4.1.2 Global Celecoxib Forecasted Sales by Type (2025-2030)

4.1.3 Global Celecoxib Sales Market Share by Type (2019-2030)

4.2 Global Celecoxib Revenue by Type

4.2.1 Global Celecoxib Historical Revenue by Type (2019-2024)

4.2.2 Global Celecoxib Forecasted Revenue by Type (2025-2030)

4.2.3 Global Celecoxib Revenue Market Share by Type (2019-2030)

4.3 Global Celecoxib Price by Type

4.3.1 Global Celecoxib Price by Type (2019-2024)

4.3.2 Global Celecoxib Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Celecoxib Sales by Application

5.1.1 Global Celecoxib Historical Sales by Application (2019-2024)

5.1.2 Global Celecoxib Forecasted Sales by Application (2025-2030)

5.1.3 Global Celecoxib Sales Market Share by Application (2019-2030)

5.2 Global Celecoxib Revenue by Application

5.2.1 Global Celecoxib Historical Revenue by Application (2019-2024)

5.2.2 Global Celecoxib Forecasted Revenue by Application (2025-2030)

5.2.3 Global Celecoxib Revenue Market Share by Application (2019-2030)

5.3 Global Celecoxib Price by Application

5.3.1 Global Celecoxib Price by Application (2019-2024)

5.3.2 Global Celecoxib Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Celecoxib Market Size by Type

6.1.1 US & Canada Celecoxib Sales by Type (2019-2030)

6.1.2 US & Canada Celecoxib Revenue by Type (2019-2030)

6.2 US & Canada Celecoxib Market Size by Application

6.2.1 US & Canada Celecoxib Sales by Application (2019-2030)

6.2.2 US & Canada Celecoxib Revenue by Application (2019-2030)

6.3 US & Canada Celecoxib Market Size by Country

6.3.1 US & Canada Celecoxib Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Celecoxib Sales by Country (2019-2030)

6.3.3 US & Canada Celecoxib Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Celecoxib Market Size by Type

7.1.1 Europe Celecoxib Sales by Type (2019-2030)

7.1.2 Europe Celecoxib Revenue by Type (2019-2030)

7.2 Europe Celecoxib Market Size by Application

7.2.1 Europe Celecoxib Sales by Application (2019-2030)

7.2.2 Europe Celecoxib Revenue by Application (2019-2030)

7.3 Europe Celecoxib Market Size by Country

7.3.1 Europe Celecoxib Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Celecoxib Sales by Country (2019-2030)

7.3.3 Europe Celecoxib Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Celecoxib Market Size

8.1.1 China Celecoxib Sales (2019-2030)

8.1.2 China Celecoxib Revenue (2019-2030)

8.2 China Celecoxib Market Size by Application

8.2.1 China Celecoxib Sales by Application (2019-2030)

8.2.2 China Celecoxib Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Celecoxib Market Size by Type

9.1.1 Asia Celecoxib Sales by Type (2019-2030)

9.1.2 Asia Celecoxib Revenue by Type (2019-2030)

9.2 Asia Celecoxib Market Size by Application

9.2.1 Asia Celecoxib Sales by Application (2019-2030)

9.2.2 Asia Celecoxib Revenue by Application (2019-2030)

9.3 Asia Celecoxib Sales by Region

9.3.1 Asia Celecoxib Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Celecoxib Revenue by Region (2019-2030)

9.3.3 Asia Celecoxib Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Celecoxib Market Size by Type

10.1.1 Middle East, Africa and Latin America Celecoxib Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Celecoxib Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Celecoxib Market Size by Application

10.2.1 Middle East, Africa and Latin America Celecoxib Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Celecoxib Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Celecoxib Sales by Country

10.3.1 Middle East, Africa and Latin America Celecoxib Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Celecoxib Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Celecoxib Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Pfizer Inc

11.1.1 Pfizer Inc Company Information

11.1.2 Pfizer Inc Overview

11.1.3 Pfizer Inc Celecoxib Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Pfizer Inc Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Pfizer Inc Recent Developments

11.2 Teva

11.2.1 Teva Company Information

11.2.2 Teva Overview

11.2.3 Teva Celecoxib Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Teva Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Teva Recent Developments

11.3 Mylan

11.3.1 Mylan Company Information

11.3.2 Mylan Overview

11.3.3 Mylan Celecoxib Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Mylan Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Mylan Recent Developments

11.4 Apotex

11.4.1 Apotex Company Information

11.4.2 Apotex Overview

11.4.3 Apotex Celecoxib Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Apotex Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Apotex Recent Developments

11.5 Lupin

11.5.1 Lupin Company Information

11.5.2 Lupin Overview

11.5.3 Lupin Celecoxib Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Lupin Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Lupin Recent Developments

11.6 Hengrui Medicine

11.6.1 Hengrui Medicine Company Information

11.6.2 Hengrui Medicine Overview

11.6.3 Hengrui Medicine Celecoxib Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Hengrui Medicine Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Hengrui Medicine Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Celecoxib Industry Chain Analysis

12.2 Celecoxib Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Celecoxib Production Mode & Process

12.4 Celecoxib Sales and Marketing

12.4.1 Celecoxib Sales Channels

12.4.2 Celecoxib Distributors

12.5 Celecoxib Customers

13 Market Dynamics

13.1 Celecoxib Industry Trends

13.2 Celecoxib Market Drivers

13.3 Celecoxib Market Challenges

13.4 Celecoxib Market Restraints

14 Key Findings in The Global Celecoxib Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

TEVA

Mylan NV

Apotex

Lupin Ltd

Hengrui Medicine

List of Tables

Table 1. Global Celecoxib Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of 50mg

Table 3. Major Manufacturers of 100mg

Table 4. Major Manufacturers of 200mg

Table 5. Major Manufacturers of 400mg

Table 6. Global Celecoxib Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Celecoxib Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Celecoxib Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Celecoxib Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Celecoxib Revenue Market Share by Region (2019-2024)

Table 11. Global Celecoxib Revenue Market Share by Region (2025-2030)

Table 12. Global Celecoxib Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Celecoxib Sales by Region (2019-2024) & (K Units)

Table 14. Global Celecoxib Sales by Region (2025-2030) & (K Units)

Table 15. Global Celecoxib Sales Market Share by Region (2019-2024)

Table 16. Global Celecoxib Sales Market Share by Region (2025-2030)

Table 17. Global Celecoxib Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Celecoxib Sales Share by Manufacturers (2019-2024)

Table 19. Global Celecoxib Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Celecoxib Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Celecoxib, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Celecoxib Price by Manufacturers 2019-2024 (US$/Unit)

Table 23. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Celecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2023)

Table 25. Global Key Manufacturers of Celecoxib, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Celecoxib, Product Offered and Application

Table 27. Global Key Manufacturers of Celecoxib, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Celecoxib Sales by Type (2019-2024) & (K Units)

Table 30. Global Celecoxib Sales by Type (2025-2030) & (K Units)

Table 31. Global Celecoxib Sales Share by Type (2019-2024)

Table 32. Global Celecoxib Sales Share by Type (2025-2030)

Table 33. Global Celecoxib Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Celecoxib Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Celecoxib Revenue Share by Type (2019-2024)

Table 36. Global Celecoxib Revenue Share by Type (2025-2030)

Table 37. Celecoxib Price by Type (2019-2024) & (US$/Unit)

Table 38. Global Celecoxib Price Forecast by Type (2025-2030) & (US$/Unit)

Table 39. Global Celecoxib Sales by Application (2019-2024) & (K Units)

Table 40. Global Celecoxib Sales by Application (2025-2030) & (K Units)

Table 41. Global Celecoxib Sales Share by Application (2019-2024)

Table 42. Global Celecoxib Sales Share by Application (2025-2030)

Table 43. Global Celecoxib Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Celecoxib Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Celecoxib Revenue Share by Application (2019-2024)

Table 46. Global Celecoxib Revenue Share by Application (2025-2030)

Table 47. Celecoxib Price by Application (2019-2024) & (US$/Unit)

Table 48. Global Celecoxib Price Forecast by Application (2025-2030) & (US$/Unit)

Table 49. US & Canada Celecoxib Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Celecoxib Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Celecoxib Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Celecoxib Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Celecoxib Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Celecoxib Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Celecoxib Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Celecoxib Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Celecoxib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Celecoxib Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Celecoxib Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Celecoxib Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Celecoxib Sales by Country (2025-2030) & (K Units)

Table 62. Europe Celecoxib Sales by Type (2019-2024) & (K Units)

Table 63. Europe Celecoxib Sales by Type (2025-2030) & (K Units)

Table 64. Europe Celecoxib Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Celecoxib Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Celecoxib Sales by Application (2019-2024) & (K Units)

Table 67. Europe Celecoxib Sales by Application (2025-2030) & (K Units)

Table 68. Europe Celecoxib Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Celecoxib Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Celecoxib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Celecoxib Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Celecoxib Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Celecoxib Sales by Country (2019-2024) & (K Units)

Table 74. Europe Celecoxib Sales by Country (2025-2030) & (K Units)

Table 75. China Celecoxib Sales by Type (2019-2024) & (K Units)

Table 76. China Celecoxib Sales by Type (2025-2030) & (K Units)

Table 77. China Celecoxib Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Celecoxib Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Celecoxib Sales by Application (2019-2024) & (K Units)

Table 80. China Celecoxib Sales by Application (2025-2030) & (K Units)

Table 81. China Celecoxib Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Celecoxib Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Celecoxib Sales by Type (2019-2024) & (K Units)

Table 84. Asia Celecoxib Sales by Type (2025-2030) & (K Units)

Table 85. Asia Celecoxib Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Celecoxib Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Celecoxib Sales by Application (2019-2024) & (K Units)

Table 88. Asia Celecoxib Sales by Application (2025-2030) & (K Units)

Table 89. Asia Celecoxib Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Celecoxib Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Celecoxib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Celecoxib Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Celecoxib Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Celecoxib Sales by Region (2019-2024) & (K Units)

Table 95. Asia Celecoxib Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Celecoxib Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Celecoxib Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Celecoxib Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Celecoxib Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Celecoxib Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Celecoxib Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Celecoxib Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Celecoxib Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Celecoxib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Celecoxib Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Celecoxib Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Celecoxib Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Celecoxib Sales by Country (2025-2030) & (K Units)

Table 109. Pfizer Inc Company Information

Table 110. Pfizer Inc Description and Major Businesses

Table 111. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 112. Pfizer Inc Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Pfizer Inc Recent Developments

Table 114. Teva Company Information

Table 115. Teva Description and Major Businesses

Table 116. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 117. Teva Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Teva Recent Developments

Table 119. Mylan Company Information

Table 120. Mylan Description and Major Businesses

Table 121. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 122. Mylan Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Mylan Recent Developments

Table 124. Apotex Company Information

Table 125. Apotex Description and Major Businesses

Table 126. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 127. Apotex Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Apotex Recent Developments

Table 129. Lupin Company Information

Table 130. Lupin Description and Major Businesses

Table 131. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 132. Lupin Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Lupin Recent Developments

Table 134. Hengrui Medicine Company Information

Table 135. Hengrui Medicine Description and Major Businesses

Table 136. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 137. Hengrui Medicine Celecoxib Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Hengrui Medicine Recent Developments

Table 139. Key Raw Materials Lists

Table 140. Raw Materials Key Suppliers Lists

Table 141. Celecoxib Distributors List

Table 142. Celecoxib Customers List

Table 143. Celecoxib Market Trends

Table 144. Celecoxib Market Drivers

Table 145. Celecoxib Market Challenges

Table 146. Celecoxib Market Restraints

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Celecoxib Product Picture

Figure 2. Global Celecoxib Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Celecoxib Market Share by Type in 2023 & 2030

Figure 4. 50mg Product Picture

Figure 5. 100mg Product Picture

Figure 6. 200mg Product Picture

Figure 7. 400mg Product Picture

Figure 8. Global Celecoxib Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Celecoxib Market Share by Application in 2023 & 2030

Figure 10. Rheumatoid arthritis

Figure 11. osteoarthritis

Figure 12. Acute pain

Figure 13. Musculoskeletal pain

Figure 14. Other diseases

Figure 15. Celecoxib Report Years Considered

Figure 16. Global Celecoxib Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Celecoxib Revenue 2019-2030 (US$ Million)

Figure 18. Global Celecoxib Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 19. Global Celecoxib Revenue Market Share by Region (2019-2030)

Figure 20. Global Celecoxib Sales 2019-2030 ((K Units)

Figure 21. Global Celecoxib Sales Market Share by Region (2019-2030)

Figure 22. US & Canada Celecoxib Sales YoY (2019-2030) & (K Units)

Figure 23. US & Canada Celecoxib Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Europe Celecoxib Sales YoY (2019-2030) & (K Units)

Figure 25. Europe Celecoxib Revenue YoY (2019-2030) & (US$ Million)

Figure 26. China Celecoxib Sales YoY (2019-2030) & (K Units)

Figure 27. China Celecoxib Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Asia (excluding China) Celecoxib Sales YoY (2019-2030) & (K Units)

Figure 29. Asia (excluding China) Celecoxib Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Middle East, Africa and Latin America Celecoxib Sales YoY (2019-2030) & (K Units)

Figure 31. Middle East, Africa and Latin America Celecoxib Revenue YoY (2019-2030) & (US$ Million)

Figure 32. The Celecoxib Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 33. The Top 5 and 10 Largest Manufacturers of Celecoxib in the World: Market Share by Celecoxib Revenue in 2023

Figure 34. Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 35. Global Celecoxib Sales Market Share by Type (2019-2030)

Figure 36. Global Celecoxib Revenue Market Share by Type (2019-2030)

Figure 37. Global Celecoxib Sales Market Share by Application (2019-2030)

Figure 38. Global Celecoxib Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Celecoxib Sales Market Share by Type (2019-2030)

Figure 40. US & Canada Celecoxib Revenue Market Share by Type (2019-2030)

Figure 41. US & Canada Celecoxib Sales Market Share by Application (2019-2030)

Figure 42. US & Canada Celecoxib Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Celecoxib Revenue Share by Country (2019-2030)

Figure 44. US & Canada Celecoxib Sales Share by Country (2019-2030)

Figure 45. U.S. Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 46. Canada Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 47. Europe Celecoxib Sales Market Share by Type (2019-2030)

Figure 48. Europe Celecoxib Revenue Market Share by Type (2019-2030)

Figure 49. Europe Celecoxib Sales Market Share by Application (2019-2030)

Figure 50. Europe Celecoxib Revenue Market Share by Application (2019-2030)

Figure 51. Europe Celecoxib Revenue Share by Country (2019-2030)

Figure 52. Europe Celecoxib Sales Share by Country (2019-2030)

Figure 53. Germany Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 54. France Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 55. U.K. Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 56. Italy Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 57. Russia Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 58. China Celecoxib Sales Market Share by Type (2019-2030)

Figure 59. China Celecoxib Revenue Market Share by Type (2019-2030)

Figure 60. China Celecoxib Sales Market Share by Application (2019-2030)

Figure 61. China Celecoxib Revenue Market Share by Application (2019-2030)

Figure 62. Asia Celecoxib Sales Market Share by Type (2019-2030)

Figure 63. Asia Celecoxib Revenue Market Share by Type (2019-2030)

Figure 64. Asia Celecoxib Sales Market Share by Application (2019-2030)

Figure 65. Asia Celecoxib Revenue Market Share by Application (2019-2030)

Figure 66. Asia Celecoxib Revenue Share by Region (2019-2030)

Figure 67. Asia Celecoxib Sales Share by Region (2019-2030)

Figure 68. Japan Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 69. South Korea Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 70. China Taiwan Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 71. Southeast Asia Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 72. India Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 73. Middle East, Africa and Latin America Celecoxib Sales Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Celecoxib Revenue Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Celecoxib Sales Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Celecoxib Revenue Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Celecoxib Revenue Share by Country (2019-2030)

Figure 78. Middle East, Africa and Latin America Celecoxib Sales Share by Country (2019-2030)

Figure 79. Brazil Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 80. Mexico Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 81. Turkey Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 82. Israel Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 83. GCC Countries Celecoxib Revenue (2019-2030) & (US$ Million)

Figure 84. Celecoxib Value Chain

Figure 85. Celecoxib Production Process

Figure 86. Channels of Distribution

Figure 87. Distributors Profiles

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions